Current Evidence on Molecular Mechanisms of Andrographolide in Cancer

Author:

Attri Dharam Chand1,Dhyani Praveen2,Trivedi Vijay Laxmi3,Sharma Eshita4,Ibrayeva Manshuk5,Jantwal Arvind6,Sati Priyanka7,Calina Daniela8,Sharifi-Rad Javad9ORCID

Affiliation:

1. Department of Botany, Central University of Jammu, Rahya-Suchani (Bagla)-181143, Jammu and Kashmir, India

2. University of Koblenz, Institute for Integrated Natural Sciences, Koblenz Germany

3. High Altitude Plant Physiology Research Centre (HAPPRC), HNB. Garhwal University (A Central University), Srinagar Garhwal-246174, Uttarakhand, India

4. Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar-143005, Punjab, India

5. Faculty of Science and Technology, The Caspian University of Technology and Engineering, named after Sh.Yessenov, Aktau, Kazakhstan

6. Department of Pharmaceutical Sciences, Kumaun University, Bhimtal-263 136, Uttarakhand, India

7. Graphic Era University, Dehradun-248 001, Uttarakhand, India

8. Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania

9. Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador

Abstract

Abstract: Cancer, a diverse group of diseases characterized by abnormal cell growth and the potential to spread throughout the body, accounts for approximately 10 million deaths globally each year. Current cancer therapies, including chemotherapy, radiation, and various pharmacological treatments, present several challenges and potential side effects. It is important to differentiate these conventional methods, which often involve synthetic drugs, from adjuvant therapies that might be used in conjunction. As a result, there is an increasing interest in alternative therapies, particularly in agents derived from natural sources for cancer treatment. Secondary metabolites have shown promise in promoting the development of new clinical drugs with various anti-cancer mechanisms. This review focuses on the anti-cancer potential of the novel metabolite Andrographolide, extracted mainly from Andrographis paniculata. The chemopreventive properties and the ability to inhibit various signaling pathways across different types of cancers without side effects posit Andrographolide as a promising natural antitumour agent. The review identified that Andrographolide inhibits multiple signaling pathways, contributing to its anti-proliferative, anti-metastatic, and apoptotic effects in various cancers. The compound's natural origin and lack of adverse side effects make it particularly attractive as a therapeutic agent. However, further detailed studies are needed to fully understand its specific mechanisms and potential clinical applications. Andrographolide presents a compelling option as a natural anticancer agent with the potential to overcome some limitations of traditional cancer treatments. Its broad spectrum of anti-cancer activities and absence of side effects highlight its therapeutic potential. The review highlights that continued research and clinical studies are important for confirming the effectiveness and safety of Andrographolide in human use, alongside optimizing dosage and delivery techniques.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3